Edition:
United Kingdom

Agenus Inc (AGEN.OQ)

AGEN.OQ on NASDAQ Stock Exchange Capital Market

2.96USD
22 Aug 2019
Change (% chg)

$0.01 (+0.34%)
Prev Close
$2.95
Open
$2.97
Day's High
$3.00
Day's Low
$2.88
Volume
285,191
Avg. Vol
260,492
52-wk High
$3.86
52-wk Low
$1.55

About

Agenus Inc. (Agenus) is an immuno-oncology (I-O) company. The Company focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. It is developing a I-O portfolio driven by platforms and programs, such as antibody discovery platforms, including Retrocyte Display, SECANT yeast... (more)

Overall

Beta: 2.17
Market Cap(Mil.): $409.77
Shares Outstanding(Mil.): 87.00
Dividend: --
Yield (%): --

Financials

  AGEN.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -1.27 -- --
ROI: -75.39 8.95 14.48
ROE: -- 10.09 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates